SBIR/STTR Research Award

Rapid Microfluidic Production of Multiple PET Biomarkers

Award identifier 04e0db6c270901e88afcc21918c6b12ad2c91800cd66cfcf3fc02c7a055a4c09Awarding agency Department of Energy

Award amount

$99,638

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Energy
Branch
Not reported
Recipient company
NANOTEK, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
DE-FG02-06ER06-09
Topic code
04

Research abstract

78966S The DOE has expressed a need for novel probes for biomedical applications as well as radio tracers for functional molecular imaging. Synthesis of novel probes and radiotracers, particularly new PET biomarkers, is difficult and costly and is limiting the utility of PET imaging technology. There is a need for rapid production of multiple and novel biomakers with PET radiolabels from a single synthesis device, which can be routinely operated by clinical and research staff. This project will develop a microfluidic platform for high speed organic synthesis and flow-based purification of PET biomarkers, with closed-loop feedback for continuous yield optimization. The device will be capable of producing multiple biomarkers in less than 60 seconds by operating in parallel with interchangeable cartridges. Only microliter quantities of reagents will be consumed and minimal user setup will be required. In Phase I, the microfluidic circuit will be designed to support closed-loop production of biomarkers with [F-18] fluoride ion labels. A prototype synthesis platform will be fabricated, characterized, and used to synthesize fluorodeoxyglucose (FDG) as a demonstration of feasibility. Commercial Applications and Other Benefits as described by the awardee: The microfluidic synthesis platform should enable PET researchers to rapidly synthesize and optimize new biomarkers while consuming only microliter quantities of costly reagents. The same device can transition from research to clinical biomarker production, leveraging fast reaction speed and low reagent costs to deliver new and more specific biomarkers at significantly lower costs compared to conventional automated chemistry. Sterile disposable reactor and reagent cartridges should provide a recurring market as well.

Technology keywords

Not reported

Agency intelligence

Department of Energy

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.